Nano Laboratories Pprivate Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -76.76%
- Ebitda -78.21%
- Net Worth -16.73%
- Total Assets 4.67%
About Nano Laboratories Pprivate
Nano Laboratories Pprivate Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 December 2005 and has a history of 19 years and two months. Its registered office is in Amritsar., Punjab.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Maninder Kaur, Balwant Singh, and Sobhveer Sandhu serve as directors at the Company.
Company Details
- Location Amritsar., Punjab
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U00304PB2005PTC029409
- Company No.
029409
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Nano Laboratories Pprivate?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maninder Kaur  | Director | 22-Dec-2005 | Current |
| Balwant Singh | Director | 22-Dec-2005 | Current |
| Sobhveer Sandhu | Director | 14-Jan-2022 | Current |
Financial Performance of Nano Laboratories Pprivate.
Nano Laboratories Pprivate Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 76.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nano Laboratories Pprivate?
In 2021, Nano Laboratories Pprivate had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Acculine Diagnostics Private LimitedManinder Kaur is a mutual person
- Nano Biotech Private Limited
Maninder Kaur, Balwant Singh and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nano Laboratories Pprivate?
Unlock and access historical data on people associated with Nano Laboratories Pprivate, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nano Laboratories Pprivate, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nano Laboratories Pprivate's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.